At Medlab Middle East 2025, held from February 3 to 6 at the Dubai World Trade Centre, ProGnosis Biotech reaffirmed its commitment to advancing clinical diagnostics and hygiene monitoring with solutions designed to set new industry standards.

At Stand H1.D11, visitors discovered our ATP-Flow Surface and ATP-Flow Total Water solutions, designed for rapid and reliable contamination detection in medical and laboratory environments. With real-time contamination insights, these tools help facilities maintain strict hygiene standards and enhance patient safety.

Alongside ATP monitoring, ProGnosis Biotech showcased high-precision IVD solutions, consisting of lateral flow and ELISA tests, designed to improve diagnostic accuracy. Attendees had the opportunity to learn more about our custom contract manufacturing services from our team of specialists, offering end-to-end support from concept to commercialization.

Medlab Middle East 2025 was an excellent opportunity to connect with industry professionals from Middle East and Asia and demonstrate how ProGnosis Biotech is driving innovation in diagnostics and hygiene monitoring. We thank everyone who visited our stand and look forward to shaping the future of healthcare together.